Document is current
Any future updates will be listed below
-
Authors
Wu, Qinglong https://orcid.org/0000-0003-3473-075X
Boonma, Prapaporn https://orcid.org/0000-0001-7467-839X
Badu, Shyam
Yalcinkaya, Nazli
So, Sik Yu https://orcid.org/0000-0003-2701-0084
Garey, Kevin W.
Williams, Kent
Arnold, L. Eugene https://orcid.org/0000-0002-0886-0692
Shulman, Robert J.
Kellermayer, Richard
Savidge, Tor C. https://orcid.org/0000-0001-5716-5357
- License Information
-
More Information
Article History
Received: 24 March 2023
Accepted: 20 July 2023
First Online: 3 August 2023
Competing interests
: T.C.S. received research funding from Merck, Nivalis, Cubist, Mead Johnson, Rebiotix, BioFire, Assembly BioSciences, and has served on the advisory board for Rebiotix and BioFire. K.W.G received research funding from Acurx, Paratek, and Seres Health. The remaining authors disclose no conflicts.
